Site for I4V-MC-JAJD - A Randomized Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Rheumatoid Arthritis
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Have a diagnosis of adult-onset Rheumatoid Arthritis (RA)
    2. If RA symptom onset is <6 months, are rheumatoid factor or anticitrullinated antibody positive
    3. Be clinically suitable, in the investigator's opinion, t

You may not be eligible for this study if the following are true:

    1. Have any contraindications to a TNF inhibitor
    2. Are pregnant or breastfeeding
    3. Have a history of VTE (DVT/PE) within 12 weeks prior to randomization
    4. Have active primary or recurrent malignant disease

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.